SHI-LYNNE BERNARD: Open Payments
NPI 1700343647 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 33 payments from 14 companies in 2025. Trend: 2023 $766 · 2024 $624 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 6 | $171 |
| Boston Scientific Corporation | 5 | $97 |
| Novartis Pharmaceuticals Corporation | 5 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Abbott Laboratories | 2 | $44 |
| PFIZER INC. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: LEQVIO, LifeVest, VYNDAQEL, Kerendia, JARDIANCE, ELIQUIS, General - EP, VERQUVO.
Industry payments across FL — which companies pay providers there.
